Patient demographic and clinical characteristics
| . | High Risk (RO+) . | Low Risk (RO–) . | ||
|---|---|---|---|---|
| . | A . | B . | C . | D . |
| Patients | 115 | 120 | 98 | 89 |
| Gender | ||||
| Male | 61 (53%) | 63 (53%) | 56 (57%) | 45 (51%) |
| Female | 54 (47%) | 56 (47%) | 42 (43%) | 43 (49%)* |
| Age at diagnosis (y) | ||||
| Evaluable | 111 | 116 | 94 | 85 |
| Median | 1.1 | 1.1 | 2.1 | 2.2 |
| Minimum | 0 | 0.01 | 0 | 0.1 |
| Maximum | 16.8 | 17.3 | 17.5 | 17.4 |
| Younger than 2 y | 81 (73%) | 90 (78%) | 44 (47%) | 41 (48%) |
| Risk organ involvement | ||||
| Liver | 56 (49%) | 62 (52%) | None | |
| Spleen | 44 (38%) | 40 (33%) | ||
| Hematopoietic system | 43 (37%) | 49 (41%) | ||
| Lungs | 57 (50%) | 52 (43%) | ||
| . | High Risk (RO+) . | Low Risk (RO–) . | ||
|---|---|---|---|---|
| . | A . | B . | C . | D . |
| Patients | 115 | 120 | 98 | 89 |
| Gender | ||||
| Male | 61 (53%) | 63 (53%) | 56 (57%) | 45 (51%) |
| Female | 54 (47%) | 56 (47%) | 42 (43%) | 43 (49%)* |
| Age at diagnosis (y) | ||||
| Evaluable | 111 | 116 | 94 | 85 |
| Median | 1.1 | 1.1 | 2.1 | 2.2 |
| Minimum | 0 | 0.01 | 0 | 0.1 |
| Maximum | 16.8 | 17.3 | 17.5 | 17.4 |
| Younger than 2 y | 81 (73%) | 90 (78%) | 44 (47%) | 41 (48%) |
| Risk organ involvement | ||||
| Liver | 56 (49%) | 62 (52%) | None | |
| Spleen | 44 (38%) | 40 (33%) | ||
| Hematopoietic system | 43 (37%) | 49 (41%) | ||
| Lungs | 57 (50%) | 52 (43%) | ||
Gender was not reported in 1 patient.